Commentary - (2025) Volume 10, Issue 6
Received: 01-Dec-2025, Manuscript No. jdcm-26-182226;
Editor assigned: 03-Dec-2025, Pre QC No. P-182226;
Reviewed: 17-Dec-2025, QC No. Q-182226;
Revised: 22-Dec-2025, Manuscript No. R-182226;
Published:
29-Dec-2025
, DOI: 10.37421/2475-3211.2025.10.344
Citation: Minh, Nguyen Thi. ”Mitochondrial Dysfunction and Diabetic Organ Damage.” J Diabetic Complications Med 10 (2025):344.
Copyright: © 2025 Minh T. Nguyen This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Mitochondrial dysfunction emerges as a central and pervasive mechanism underlying the development of organ damage in the context of diabetes mellitus. This cellular impairment significantly contributes to the multifaceted complications that arise from the metabolic derangements characteristic of the disease. The intricate cellular machinery within mitochondria, responsible for energy production and cellular signaling, becomes a focal point of pathological processes when subjected to the prolonged metabolic stress of hyperglycemia and its associated sequelae. The impairment of mitochondrial respiration, a fundamental process for generating cellular energy in the form of ATP, is a hallmark of diabetic organ damage. This compromised energy production directly impacts the functional capacity of cells, particularly in highly metabolically active organs. Such a decline in energy supply can precipitate cellular dysfunction and, ultimately, cell death, contributing to the progressive loss of organ function observed in diabetic complications. Concurrently, an increased production of reactive oxygen species (ROS) is another critical consequence of mitochondrial dysfunction in diabetes. While ROS are naturally produced during normal cellular respiration, an excessive surge, often referred to as oxidative stress, overwhelms the cell's antioxidant defenses. This imbalance can lead to significant damage to cellular macromolecules, including DNA, proteins, and lipids, further exacerbating cellular injury. Altered mitochondrial dynamics, encompassing processes like fission and fusion, also play a significant role in the pathogenesis of diabetic organ damage. The balance between these processes is crucial for maintaining a healthy mitochondrial network. Disruptions to this dynamic equilibrium can lead to fragmented or aggregated mitochondria, both of which are associated with impaired function and increased cellular stress. These interconnected mitochondrial abnormalities contribute to cellular injury across a spectrum of vital organs. The heart, kidneys, liver, and eyes are particularly susceptible to the detrimental effects of mitochondrial dysfunction in the diabetic state. Each organ exhibits unique responses, but the underlying mitochondrial pathology is a common thread weaving through the diverse clinical manifestations of diabetic complications. In the renal system, the intricate interplay between hyperglycemia, inflammation, and oxidative stress directly targets renal cells. This leads to significant mitochondrial damage within these cells. The compromised state of mitochondria in kidney cells exacerbates key pathological processes that define diabetic nephropathy, a leading cause of kidney failure. The heart is also profoundly affected, with diabetic cardiomyopathy being a significant clinical concern. This condition is characterized by structural and functional changes in the cardiac muscle, and mitochondrial dysfunction is recognized as a pivotal contributor to its development and progression. The heart's high energy demand makes it particularly vulnerable to mitochondrial impairments. The liver, a central metabolic hub, is similarly susceptible to damage mediated by mitochondrial dysfunction in diabetes. Impaired metabolic processes within hepatic mitochondria, such as fatty acid oxidation, contribute to the development of liver-related complications. This can manifest as non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH). Vision loss due to diabetic retinopathy is another major concern, with mitochondrial dysfunction within retinal cells playing a significant role. The delicate vascular network of the retina is highly sensitive to metabolic disturbances, and mitochondrial impairments contribute to the characteristic pathological changes that impair vision. Given the central role of mitochondria in the pathophysiology of diabetic organ damage, targeting mitochondrial pathways offers promising therapeutic avenues. Strategies aimed at restoring mitochondrial function, reducing oxidative stress, and re-establishing cellular homeostasis hold the potential for preventing or reversing the progression of these debilitating diabetic complications. [1]
Mitochondrial dysfunction is identified as a central mechanism contributing to organ damage in individuals with diabetes mellitus. This cellular pathology underpins a range of complications affecting various organ systems. The multifaceted nature of diabetic organ damage often originates from subtle yet profound alterations in mitochondrial function, impacting energy production, cellular signaling, and the generation of harmful byproducts. The impairment of mitochondrial respiration is a key factor in the cellular demise observed in diabetic organs. This diminished capacity for ATP synthesis compromises the energy demands of metabolically active cells, leading to a cascade of detrimental effects. As cellular energy stores dwindle, essential physiological processes falter, paving the way for irreversible damage and functional decline in organs such as the heart and kidneys. Furthermore, the increased production of reactive oxygen species (ROS) by dysfunctional mitochondria generates significant oxidative stress. This imbalance between ROS generation and the cell's antioxidant capacity can inflict widespread damage to cellular components. Proteins, lipids, and DNA are all vulnerable targets, leading to cellular injury and contributing to the chronic inflammatory state often seen in diabetic complications. Altered mitochondrial dynamics, specifically the processes of fission and fusion, are also implicated in diabetic organ damage. The precise regulation of these events is critical for maintaining a healthy and functional mitochondrial network. When this balance is disrupted, it can lead to fragmented or dysfunctional mitochondria, exacerbating cellular stress and contributing to organ pathology. These mitochondrial aberrations contribute to cellular injury across a broad range of organs, including the heart, kidneys, liver, and eyes. Each organ system exhibits specific vulnerabilities, but the underlying mitochondrial dysfunction serves as a common pathogenic link across these diverse complications. The cumulative effect of these localized insults can lead to significant systemic morbidity. In the context of the kidneys, the interplay between hyperglycemia, inflammation, and oxidative stress leads to profound mitochondrial damage within renal cells. This dysfunction is a primary driver of diabetic nephropathy, a leading cause of end-stage renal disease worldwide, by damaging podocytes and exacerbating tubulointerstitial fibrosis. Diabetic cardiomyopathy, a serious complication affecting the heart, is characterized by structural and functional cardiac changes where mitochondrial dysfunction plays a pivotal role. Alterations in ATP production, calcium handling, and ROS generation contribute to myocyte apoptosis and fibrosis, ultimately leading to heart failure. The liver in diabetic individuals is also susceptible to damage driven by mitochondrial dysfunction. Impaired fatty acid oxidation and increased de novo lipogenesis, stemming from mitochondrial defects, contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Diabetic retinopathy, a major cause of vision loss, involves significant mitochondrial dysfunction within retinal cells. Hyperglycemia-induced oxidative stress and impaired mitochondrial biogenesis contribute to endothelial cell dysfunction, vascular leakage, and the neovascularization characteristic of this vision-threatening complication. Modulation of mitochondrial fission and fusion dynamics is critical in preventing diabetic organ damage. Imbalances in these processes, often triggered by hyperglycemia, lead to mitochondrial fragmentation and impaired function, contributing to the overall pathology across various diabetic complications. [2]
Mitochondrial dysfunction is a central mechanism in diabetic organ damage, affecting the heart, kidneys, liver, and eyes. Key issues include impaired mitochondrial respiration, increased reactive oxygen species (ROS) production, and altered mitochondrial dynamics. These factors lead to cellular injury, contributing to complications like diabetic nephropathy, cardiomyopathy, fatty liver disease, and retinopathy. Targeting mitochondrial pathways represents a promising therapeutic strategy for mitigating these diabetic complications.
None
None
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report
